Ligand validation:7HIJ

W3S: [1,2,4]triazolo[4,3-a]pyridin-3-amine

W3S is a Ligand Of Interest in 7HIJ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7HIJ_W3S_C_207	26%	62%	0.171	0.812	0.74	0.72	-	-	0	0	100%	0.65
7HIJ_W3S_D_208	22%	61%	0.172	0.787	0.74	0.75	-	-	0	0	100%	0.65
7HIJ_W3S_B_207	19%	63%	0.218	0.815	0.72	0.68	-	-	0	0	100%	0.65
7HIJ_W3S_A_210	14%	63%	0.216	0.77	0.72	0.69	-	-	0	0	100%	0.65
7H8J_W3S_C_206	33%	68%	0.128	0.805	0.62	0.6	-	-	0	0	100%	0.92
7HIK_W3S_C_207	9%	63%	0.231	0.716	0.73	0.7	-	-	0	0	100%	0.52
7H1T_W3S_B_202	71%	62%	0.087	0.905	0.77	0.7	-	-	0	0	100%	0.86
7GQF_W3S_A_201	11%	63%	0.202	0.715	0.7	0.7	-	-	0	0	100%	0.66
7H55_W3S_B_201	0%	63%	0.324	0.332	0.77	0.65	-	-	0	0	100%	0.48

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.